In view of the problems with opting out patents from the Unified Patent Court’s jurisdiction, the court will temporarily accept opt out applications in hard copy in case the CMS ceases to function. Just six days before the Unified Patent Court opens its doors, the court has announced that taking into account the ‘sharp increase of…
The European Patent Convention (EPC) is used daily by many patent practitioners and is essential reading for the thousands of candidates taking the European Qualifying Examination (EQE) each year. Since 1994, Visser’s Annotated European Patent Convention has been providing valuable insights into the EPC to help attorneys practise successfully before the European Patent Office (EPO)….
The Unified Patent Court has temporarily restricted non-essential functions of the CMS, in its endeavour to ensure that users who want to file opt-outs can do so within the Sunrise period. In an announcement on its website, the court says: ‘In view of the approaching end of the Sunrise period, we are striving to ensure…
With less than 2 weeks to go before 1 June 2023, it was about time for the UPC to tie several loose ends and to clarify various questions before becoming (more or less) fully operative. Here is an overview of what I found to be the most interesting news. 1.) Seat of the 3rd Subdivision…
The Italian Government has agreed with France and Germany to set up a branch of the central division of the Unified Patent Court in Milan. This has been announced by the Italian ministry of foreign affairs and international cooperation. According to a press release, the agreement will be submitted to the other UP member states…
The Unified Patent Court has published an update on the problems with the CMS and the opting out of patents of the jurisdiction of the court before the starting date of 1 June 2023. On its website, the UPC writes: ‘Dear users of the UPC Case Management System, As you may have experienced, the CMS…
The Unified Patent Court has formally announced that, for the time being, competencies which were originally assigned to the London seat of the UPC central division, will be divided between Munich and Paris. Remarkably, there is no mention of Milan as third seat of the central division. Only two months ago, a spokesperson for the…
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc.’s Japanese patent (JP5705288) covering an isolated monoclonal antibody used as cholesterol medication, won an appeal case in the IP High Court (Case No. 2021 (Gyo-ke) 10093). What was surprising in this case was that the IP High Court’s invalidity conclusion was the…
Less than three weeks before the planned opening of the Unified Patent Court, a message has been published on its website as a reaction to problems with the content management system, which apparently isn’t able to cope with the growing inflow of opt-outs. Proprietors who don’t want their patents to fall under the UPC need…
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. The appeal decision is centred on the question of plausibility and comes hot on the heels of the Enlarged Board of Appeal’s decision in G 2/21. Indeed,…
